Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation Evaluating Medical Grade Polycaprolactone (PCL) Breast Scaffold Implantation in Conjunction With Autologous Fat Grafting for Breast Implant Revision and Primary Breast Augmentation Surgery

NCT07367698 is registered in ClinicalTrials.gov with BellaSeno Pty Ltd as lead sponsor.

NCT NCT07367698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07367698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation Evaluating Medical Grade Polycaprolactone (PCL) Breast Scaffold Implantation in Conjunction With Autologous Fat Grafting for Breast Implant Revision and Primary Breast Augmentation Surgery
Lead sponsor
BellaSeno Pty Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
February 13, 2026
Completion date
January 31, 2032
Enrollment
87 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast augmentation complications, breast implant revision, primary breast augmentation surgery